A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension

The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models

(2013) Michael G. Dickinson et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

BDNF/TrkB Signaling Augments Smooth Muscle Cell Proliferation in Pulmonary Hypertension

(2012) Grazyna Kwapiszewska et al.   AMERICAN JOURNAL OF PATHOLOGY

Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle

(2012) Marinus A.J. Borgdorff et al.   EUROPEAN JOURNAL OF HEART FAILURE

Molecular pathogenesis of pulmonary arterial hypertension

(2012) Marlene Rabinovitch   JOURNAL OF CLINICAL INVESTIGATION

Clinical features of paediatric pulmonary hypertension: a registry study

(2012) Rolf MF Berger et al.   LANCET

Role of early growth response 1 in arteriogenesis: Impact on vascular cell proliferation and leukocyte recruitment in vivo

(2012) Tibor Ziegelhoeffer et al.   THROMBOSIS AND HAEMOSTASIS

Egr-1 Expression During Neointimal Development in Flow-Associated Pulmonary Hypertension

(2011) Michael G. Dickinson et al.   AMERICAN JOURNAL OF PATHOLOGY

Mast Cell Inhibition Improves Pulmonary Vascular Remodeling in Pulmonary Hypertension

(2011) Beatrijs Bartelds et al.   CHEST

Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure

(2011) B. Rondelet et al.   EUROPEAN HEART JOURNAL

Targeted siRNA delivery to diseased microvascular endothelial cells-Cellular and molecular concepts

(2011) Piotr S. Kowalski et al.   IUBMB LIFE

Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

(2010) Marc Humbert et al.   CIRCULATION

Peroxisome-proliferator-activated receptor gamma (PPARγ) is required for modulating endothelial inflammatory response through a nongenomic mechanism

(2010) Giulia Cantini et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ

(2009) Minghua Wu et al.   AMERICAN JOURNAL OF PATHOLOGY

Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure

(2009) Kurt R. Stenmark et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Gene expression profile in flow-associated pulmonary arterial hypertension with neointimal lesions

(2009) Mirjam E. van Albada et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Reversible or Irreversible Remodeling in Pulmonary Arterial Hypertension

(2009) Seiichiro Sakao et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Rosiglitazone Attenuates Chronic Hypoxia–Induced Pulmonary Hypertension in a Mouse Model

(2009) Rachel E. Nisbet et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

The Right Ventricle Under Pressure

(2009) Harm J. Bogaard et al.   CHEST

Deoxyribozymes: useful DNA catalysts in vitro and in vivo

(2008) D. A. Baum et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Antisense Oligonucleotide Directed to Human Apolipoprotein B-100 Reduces Lipoprotein(a) Levels and Oxidized Phospholipids on Human Apolipoprotein B-100 Particles in Lipoprotein(a) Transgenic Mice

(2008) Esther Merki et al.   CIRCULATION

An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertension

(2008) Georg Hansmann et al.   JOURNAL OF CLINICAL INVESTIGATION